In the phase 3 trials, between 8 and 15% of participants didn't lose even 5% of their body weight, while others lost 30% or more
[3] That proves its possible in the lab with advanced tech, but its a far cry from the supplement-style GLP-1 patches sold online today, which dont contain semaglutide and have never been through clinical trials
(2023) Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action Muller, Neerav et al
The point is that they appear to be systemic metabolic therapies with effects that reach beyond simple appetite suppression
We also discuss nutrition and movement patterns that complement the therapy
These fibers are found in a variety of fruits, vegetables, whole grains, and legumes and beans